Vimarsana
Biggest News Aggregation in the World

Accessed October News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed October. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed October Today - Breaking & Trending Today

Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib - Vimarsana News

Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib

Ibrutinib has been selected for Medicare price negotiation under the Inflation Reduction Act. The authors summarize the House Oversight Committee investigation to be considered by CMS during the price negotiation process.

Source: ajmc.com
Alzheimer Disease and Related Dementias and the Risks of Polypharmacy - Vimarsana News

Alzheimer Disease and Related Dementias and the Risks of Polypharmacy

Older adults living with Alzheimer Disease or dementia live with more chronic conditions, managing these issues often involves medications but too much may have a greater impact on their health.

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple ... - Vimarsana News

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple ...

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3

Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open - Vimarsana News

Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced the first peer-reviewed publication of the Phase 3 portion of its pivotal, double-blind, randomized, placebo-controlled...

Organon's XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older -January 10, 2024 at 07:34 am EST - Vimarsana News

Organon's XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older -January 10, 2024 at 07:34 am EST

Despite being the most common vaginal condition,1 BV symptoms are often mistaken for a yeast infection2 ...